נוגדנים חד–שבטיים אנושיים נגד pd–l1 ושיטות שימוש

• 收藏
• 分享

专利权人:

DANA-FARBER CANCER INSTITUTE INC.

发明人:

申请号：

IL23773715

公开号：

IL237737D0

申请日:

2015.03.15

申请国别(地区):

IL

年份:

2015

代理人:

摘要：

The present invention comprises human monoclonal antibodies that bind to PD-L1 (also known as programmed death ligand 1 or B7H1). Binding of the invented antibody to PD-L1 inhibits binding to its receptor, PD1 (programmed death 1), and ligand-mediated activities and can be used to treat cancer and chronic viral infections.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/